Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation

Ayanoglu, Muge; Korgali, ELİF; Sezer, Taner; Aydin, Halil; Sonmez, Fatma

doi:10.1016/j.braindev.2020.02.001

Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation

Atıf İçin Kopyala

Ayanoglu M., Korgali E., Sezer T., Aydin H. I., Sonmez F. M.

BRAIN & DEVELOPMENT, cilt.42, sa.5, ss.418-420, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 42 Sayı: 5
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.braindev.2020.02.001
Dergi Adı: BRAIN & DEVELOPMENT
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE, Psycinfo
Sayfa Sayıları: ss.418-420
Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

We describe the first child with guanidinoacetate methyltransferase (GAMT) deficiency who developed neuroleptic malignant syndrome (NMS) after the treatment of risperidone without elevated creatine kinase (CK) levels.